Cynata Therapeutics Limited [ASX:CYP] share price and news 2022

Company Description

Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company focussing on the development and commercialisation of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which the Company has branded Cymerus.

Cynata Therapeutics Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website:

This a small cap company with market cap of 90 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 4.41 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how cyp dividend grows in the recent years.

No data